Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4

Journal of Lipid Research

Volumn 47, Issue 5, 2006, Pages 1097-1111

  Raetz, Christian R H ^a   Garrett, Teresa A ^a   Reynolds, C Michael ^a   Shaw, Walter A ^b   Moore, Jeff D ^b   Smith Jr , Dale C ^b   Ribeiro, Anthony A ^a   Murphy, Robert C ^c   Ulevitch, Richard J ^d   Fearns, Colleen ^d   Reichart, Donna ^e   Glass, Christopher K ^e   Benner, Chris ^f   Subramaniam, Shankar ^f   Harkewicz, Richard ^g   Bowers Gentry, Rebecca C ^g   Buczynski, Matthew W ^g   Cooper, Jennifer A ^g   Deems, Raymond A ^g   Dennis, Edward A ^g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Avanti Polar Lipids Inc   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 deoxy D manno octulosonic acid lipid A; Endotoxin; Escherichia coli; LIPID MAPS; Macrophage; Mass spectrometry; Re; Toll like receptor 4

Indexed keywords

KDO2 LIPID A; KDO2-LIPID A; LIPOPOLYSACCHARIDE; PROSTAGLANDIN D2; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MACROPHAGE ACTIVATION; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; SECRETION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MICE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROSTAGLANDIN D2; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TOLL-LIKE RECEPTOR 4;

EID: 33646804835     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600027-JLR200     Document Type: Article

References (67)

1. Dennis, E. A., H. A. Brown, R. Deems, C. K. Glass, A. H. Merrill, R. C. Murphy, C. R. H. Raetz, W. Shaw, S. Subramaniam, D. W. Russell, et al. 2005. The LIPID MAPS approach to lipidomics. In. Functional Lipidomics. L. Feng and G. D. Prestwich, editors. CRC Press/Taylor and Francis Group, Boca Raton, FL.1-15.
2. Murphy, R. C., J. Fiedler, and J. Hevko. 2001. Analysis of nonvolatile lipids by mass spectrometry. Chem. Rev. 101: 479-526.
3. Pulfer, M., and R. C. Murphy. 2003. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22: 332-364.
4. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, Jr., R. C. Murphy, C. R. H. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46: 839-862.
5. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406: 782-787.
6. Raetz, C. R. H., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71: 635-700.
7. Gangloff, M., and N. J. Gay. 2004. MD-2: the Toll 'gatekeeper' in endotoxin signalling. Trends Biochem. Sci. 29: 294-300.
8. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8: 217-225.
9. Brade, H., S. M. Opal, S. N. Vogel, and D. C. Morrison, editors. 1999. Endotoxin in Health and Disease. Marcel Dekker, Inc., New York.
10. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67: 593-656.
11. Ulevitch, R. J. 2004. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4: 512-520.
12. Visintin, A., K. A. Halmen, E. Latz, B. G. Monks, and D. T. Golenbock. 2005. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J. Immunol. 175: 6465-6472.
13. Lynn, M., D. P. Rossignol, J. L. Wheeler, R. J. Kao, C. A. Perdomo, R. Noveck, R. Vargas, T. D'Angelo, S. Gotzkowsky, and F. G. McMahon. 2003. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J. Infect. Dis. 187: 631-639.
14. Prabhakar, U., T. M. Conway, P. Murdock, J. L. Mooney, S. Clark, P. Hedge, B. C. Bond, E. C. Jazwinska, M. R. Barnes, F. Tobin, et al. 2005. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol. 24: 410-431.
15. Calvano, S. E., W. Xiao, D. R. Richards, R. M. Felciano, H. V. Baker, R. J. Cho, R. O. Chen, B. H. Brownstein, J. P. Cobb, S. K. Tschoeke, et al. 2005. A network-based analysis of systemic inflammation in humans. Nature. 437: 1032-1037.
16. Hawkins, L. D., W. J. Christ, and D. P. Rossignol. 2004. Inhibition of endotoxin response by synthetic TLR4 antagonists. Curr. Top. Med. Chem. 4: 1147-1171.
17. Golenbock, D. T., R. Y. Hampton, N. Qureshi, K. Takayama, and C. R. H. Raetz. 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266: 19490-19498.
18. Bryans, T. D., C. Braithwaite, J. Broad, J. F. Cooper, K. R. Darnell, V. M. Hitchins, A. J. Karren, and P. S. Lee. 2004. Bacterial endotoxin testing: a report on the methods, background, data, and regulatory history of extraction recovery efficiency. Biomed. Instrum. Technol. 38: 73-78.
19. Cohen, J. 2000. The detection and interpretation of endotoxaemia. Intensive Care Med. 26 (Suppl. 1): 51-56.
20. Brabetz, W., S. Muller-Loennies, O. Holst, and H. Brade. 1997. Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. Eur. J. Biochem. 247: 716-724.
21. Murphy, R. C., C. R. H. Raetz, C. M. Reynolds, and R. M. Barkley. 2005. Mass spectrometry advances in lipidomica: collision-induced decomposition of Kdo(2)-lipid A. Prostaglandins Other Lipid Mediat. 77: 131-140.
22. Kanipes, M. I., S. Lin, R. J. Cotter, and C. R. H. Raetz. 2001. Ca2+-induced phosphoethanolamine transfer to the outer 3-deoxy-D-manno- octulosonic acid moiety of Escherichia coli lipopolysaccharide. A novel membrane enzyme dependent upon phosphatidylethanolamine. J. Biol. Chem. 276: 1156-1163.
23. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
24. Ribeiro, A. A., Z. Zhou, and C. R. H. Raetz. 1999. Multi-dimensional NMR structural analyses of purified lipid X and lipid A (endotoxin). Magn. Reson. Chem. 37: 620-630.
25. Que, N. L. S., A. A. Ribeiro, and C. R. H. Raetz. 2000. Two-dimensional NMR spectroscopy and structures of six lipid A species from Rhizobium etli CE3. Detection of an acyloxyacyl residue in each component and origin of the aminogluconate moiety. J. Biol. Chem. 275: 28017-28027.
26. 3-treated Escherichia coli versus kdsA mutants of Salmonella typhimurium. J. Biol. Chem. 275: 13542-13551.
27. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
28. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
29. Valledor, A. F., L. C. Hsu, S. Ogawa, D. Sawka-Verhelle, M. Karin, and C. K. Glass. 2004. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. USA. 101: 17813-17818.
30. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, et al. 2005. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 122: 707-721.
31. Brozek, K. A., K. Hosaka, A. D. Robertson, and C. R. H. Raetz. 1989. Biosynthesis of lipopolysaccharide in Escherichia coli: cytoplasmic enzymes that attach 3-deoxy-D-manno-octulosonic acid to lipid A. J. Biol. Chem. 264: 6956-6966.
32. Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16: 653-699.
33. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282: 2085-2088.
34. Galanos, C., O. Lüderitz, and O. Westphal. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9: 245-249.
35. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure. In Methods in Carbohydrate Chemistry 5: R. L. Whistler, editor. Academic Press. New York, NY. 83-91.
36. Goldman, R. C., and L. Leive. 1980. Heterogeneity of antigenic side-chain length in lipopolysaccharide from Escherichia coli O111 and Salmonella typhimurium LT2. Eur. J. Biochem. 107: 145-153.
37. 252Cf plasma desorption mass spectrometry. J. Biol. Chem. 269: 31881-31884.
38. Imoto, M., H. Yoshimura, N. Sakaguchi, T. Shimamoto, S. Kusumoto, and T. Shiba. 1987. Total synthesis of Escherichia coli lipid A, the endotoxically active principle of cell-surface lipopolysaccharide. Bull. Chem. Soc. Jpn. 60: 2205-2214.
39. Yoshizaki, H., N. Fukuda, K. Sato, M. Oikawa, K. Fukase, Y. Suda, and S. Kusumoto. 2001. First total synthesis of the Re-type lipopolysaccharide. Angew. Chem. Int. Ed. Engl. 40: 1475-1480.
40. Christ, W. J., P. D. McGuinness, O. Asano, Y. Wang, M. A. Mullarkey, M. Perez, L. D. Hawkins, T. A. Blythe, G. R. Dubuc, and A. L. Robidoux. 1994. Total synthesis of the proposed structure of Rhodobacter sphaeroides lipid A resulting in the synthesis of a new potent lipopolysaccharide antagonist. J. Am. Chem. Soc. 116: 3637-3638.
41. Christ, W. J., O. Asano, A. L. Robidoux, M. Perez, Y. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. McGuinness, M. A. Mullarkey, et al. 1995. E5531, a pure endotoxin antagonist of extraordinary potency: chemistry and biology. Science. 265: 80-83.
42. Plante, O. J., and P. H. Seeberger. 2003. Recent advances in automated solid-phase carbohydrate synthesis: from screening to vaccines. Curr. Opin. Drug Discov. Devel. 6: 521-525.
43. Seeberger, P. H., and D. B. Werz. 2005. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat. Rev. Drug Discov. 4: 751-763.
44. Rosner, M. R., J. Tang, I. Barzilay, and H. G. Khorana. 1979. The structure of lipopolysaccharide from an Escherichia coli heptose-less mutant. III. Two fatty acyl amidases from Dictyostelium discoideum and their action on lipopolysaccharide derivatives. J. Biol. Chem. 254: 5906-5917.
45. Magnuson, K., S. Jackowski, C. O. Rock, and J. E. Cronan, Jr. 1993. Regulation of fatty acid biosynthesis in Escherichia coli. Microbiol. Rev. 57: 522-542.
46. Loppnow, H., H. Brade, I. Dürrbaum, C. A. Dinarello, S. Kusumoto, E. T. Rietschel, and H. D. Flad. 1989. IL-1 induction capacity of defined lipopolysaccharide partial structures. J. Immunol. 142: 3229-3238.
47. 3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. J. Biol. Chem. 274: 18503-18514.
48. Zhou, Z., A. A. Ribeiro, S. Lin, R. J. Cotter, S. I. Miller, and C. R. H. Raetz. 2001. Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose and phosphoethanolamine incorporation. J. Biol. Chem. 276: 43111-43121.
49. Qureshi, N., K. Takayama, and E. Ribi. 1982. Purification and structural determination of non-toxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257: 11808-11815.
50. Trent, M. S., W. Pabich, C. R. H. Raetz, and S. I. Miller. 2001. A PhoP/PhoQ-induced lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J. Biol. Chem. 276: 9083-9092.
51. Raetz, C. R. H. 2001. Regulated covalent modifications of lipid A. J. Endotoxin Res. 7: 73-78.
52. Karbarz, M. J., S. R. Kalb, R. J. Cotter, and C. R. H. Raetz. 2003. Expression cloning and biochemical characterization of a Rhizobium leguminosarum lipid A 1-phosphatase. J. Biol. Chem. 278: 39269-39279.
53. Tran, A. X., M. J. Karbarz, X. Wang, C. R. H. Raetz, S. C. McGrath, R. J. Cotter, and M. S. Trent. 2004. Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A. J. Biol. Chem. 279: 55780-55791.
54. Wang, X., M. J. Karbarz, S. C. McGrath, R. J. Cotter, and C. R. H. Raetz. 2004. MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of francisella novicida LpxE expressed in Escherichia coli. J. Biol. Chem. 279: 49470-49478.
55. Reynolds, C. M., S. R. Kalb, R. J. Cotter, and C. R. H. Raetz. 2005. A phosphoethanolamine transferase specific for the outer 3-deoxy-D-manno- octulosonic acid residue of Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2+ hypersensitivity of an eptB deletion mutant. J. Biol. Chem. 280: 21202-21211.
56. Trent, M. S., A. A. Ribeiro, S. Lin, R. J. Cotter, and C. R. H. Raetz. 2001. An inner membrane enzyme in Salmonella typhimurium and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction in polymyxin-resistant mutants and role of a novel lipid-linked donor. J. Biol. Chem. 276: 43122-43131.
57. Persing, D. H., R. N. Coler, M. J. Lacy, D. A. Johnson, J. R. Baldridge, R. M. Hershberg, and S. G. Reed. 2002. Taking toll: lipid A mimetics as adjuvants and immunomodulators. Trends Microbiol. 10 (Suppl.): 32-37.
58. Baldridge, J. R., P. McGowan, J. T. Evans, C. Cluff, S. Mossman, D. Johnson, and D. Persing. 2004. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4: 1129-1138.
59. Choe, J., M. S. Kelker, and I. A. Wilson. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 309: 581-585.
60. Kim, J. I., C. J. Lee, M. S. Jin, C. H. Lee, S. G. Paik, H. Lee, and J. O. Lee. 2005. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280: 11347-11351.
61. Qureshi, N., P. Mascagni, E. Ribi, and K. Takayama. 1985. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J. Biol. Chem. 260: 5271-5278.
62. Boll, M., J. Radziejewska-Lebrecht, C. Warth, D. Krajewska-Pietrasik, and H. Mayer. 1994. 4-Amino-4-deoxy-L-arabinose in LPS of enterobacterial R-mutants and its possible role for their polymyxin reactivity. FEMS Immunol. Med. Microbiol. 8: 329-341.
63. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64: 29-63.
64. Denarie, J., F. Debelle, and J-C. Prome. 1996. Rhizobium lipochitooligosaccharide nodulation factors: signalling molecules mediating recognition and morphogenesis. Annu. Rev. Biochem. 65: 503-535.
65. Clementz, T., Z. Zhou, and C. R. H. Raetz. 1997. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB Knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J. Biol. Chem. 272: 10353-10360.
66. Vorachek-Warren, M. K., S. Ramirez, R. J. Cotter, and C. R. H. Raetz. 2002. A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. J. Biol. Chem. 277: 14194-14205.
67. Bishop, R. E., H. S. Gibbons, T. Guina, M. S. Trent, S. I. Miller, and C. R. H. Raetz. 2000. Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria. EMBO J. 19: 5071-5080.